Τόμος 15 (2001) – Τεύχος 3 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 3 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Biological Chemistry Department, Medical School, University of Athens, Athens, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.    Beato M.: Gene regulation by steroid hormones. Cell 56: 335-344 (1989)

3.    Beato M., Herrlich P., Schutz G.: Steroid hormone receptors: Many actors in search of a plot. Cell 83: 851-857 (1995)

4.    Kato S., Endoh H., Masuhiro Y.p Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y.p Nishida E.P Kawashima H., Metzger D., Chambon P.: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494 (1995)

5.    Power R.F., Mani S.K., Codina J., Conneely O.M., O’Malley B.W.: Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254: 1636-1639 (1991)

6.    Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom 0., Ohman L., Greene G.L., Gustafsson J.-A., Carlquist M.: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758(1997)

7.    Grese T.A., Dodge J.A.: Selective Estrogen Receptor Modulators (SERMs). Curr. Pharmaceut. Design 4: 71-92 (1998)

8.    Murkies A.L., Wilcox G., Davis S.R.: Phytoestrogens. J. Clin. Endocrinol. Metab. 83: 297-303 (1998)

9.    Setchell K.D.R., Cassidy A.: Dietary isoflavones: Biological effects and relevance to human health. J. Nutr. 129: 758S-767S (1999)

10.  Tham D.M., Gardner C.D., Haskell W.L.: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological and mechanistic evidence. J. Clin. Endocrinol. Metab. 83: 2223-2235 (1998)

11.  Adlercreutz H., Fotsis T., Heikklinen R., Dwyer J.T., Woods M., Goidin B.R., Gorbach S.L: Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women with breast cancer. Lancet ii: 1295-1299 (1982)

12.  Adlercreutz H., Honjo H., Higashi A., Fotsis T., Hamalainen E., Hasegawa T., Okada H.: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 54: 1093-1100 (1991)

13.  Albertazzi P,, Pansini F., Bonaccorsi G., Zanotti L, Forint E., DeAtoysio D,: The effects of dietary soy supplementation on hot flushes. Obstet. Gynecol. 91: 6-11 (1998)

14.  Anderson J.J.B., Garner S.C.: Phytoestrogens and human function, Nutr. Today 32: 232-239 (1997)

15.  Duax W.L., Griffin J.F.: Structure-activity relationships of estrogenic chemicals. Proceedings of the Second Symposium on estrogens in the environment Raleigh, North Carolina, April 10-12, 1985

16.  Davis D.L., Bradlow H.: Can environmental estrogens cause breast cancer? Scientific American Oct. 144-149, 1995

17.  Miller W.R., Sharpe R.M.: Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancers: 69-96 (1998)

18.  Tian Y., Ke S., Thomas Th., Meeker R.J., Gallo M.A.: Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Steroid Biochem. Mol. Biol. 67: 17-24 (1998)

19.  O’Malley B.W.: The steroid receptor superfamily: more excitement predicted for the future. Mol. Endocr. 4: 363- 369 (1990)

20.  Evans R.M.: The steroid and thyroid hormone receptor superfamily. Science 243: 889-895 (1988)

21.  Greene G.L., Gilma P., Waterfield M., Baker A., Hort Y., Shine J.: Sequence and expression of human estrogen receptor complementary DNA. Science 231: 1150-1154 (1985)

22.  Mosseiman S., Polman J., Dijkema R.: ERp: identification and characterization of a novel human estrogen receptor. FEBS Letters 392: 49-53 (1996)

23.  Enmark E., Pelto-Huikko M., Grandlien K,, Lagercrantz S., Lagercrantz J., Fried G., Nordenskjold M., Gustafsson J.A.: Human estrogen receptor beta-gene structure, chromosomal localization and expression pattern. J. Clin. Endocrinol. Metab. 82: 4258-4265 (1997)

24.  Kuipper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and p. Endocrinology 183: 863-870 (1997)

25.  Leygue E., Huang A., Murphy L.C., Watson P.H.: Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res. 56: 4324-4327 (1996.)

26.  Erenburg J., Schachter B., Mira R. y Lopez, Ossowski L.: Loss of an estrogen receptor isoform (ERA3) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation. Mol. Endocrinol. 11: 2004-2015 (1997)

27.  Pace P., Taylor J., Suntharalingam S., Coombes R.C., Alis S.: Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J. Biol. Chem. 272: 25832-25838 (1997)

28.  Beato M., Sanchez-Pacheco A.: Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev.: 587-609 (1996)

29.  Ali S., Metzger D., Bornet J.-M., Chambon P.: Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBOJ. 1: 1153-1160 (1993)

30.  Bunone G., Briand P.A., Miksicek R.J., Picand D.: Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBOJ. 15: 2174-2183 (1996)

31.  Wehling M.: Specific nongenomic actions of steroid hormones. Ann Rev Physiol 59: 365-393, 1997,

32.  Kuiper G.G.J.M., Carlsson B., Grandten K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870 (1997)

33.  Yang N.N., Venugopalan M., Hardikar S., Glasebrook A.: Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273: 1222-1225 (1996)

34.  Messina M., Barnes S., Setchell K.D.R. (editorial): Phyto-oestrogens and breast cancer. Lancet 350: 971-972 (1997)

35.  Adlercreutz H.: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ. Health Perspect. 103: 103-111 (1995)

36.  Lip G.Y., Blann A.D., Jones A.F., Beevers D.G.: Effects of hormone-replacement therapy on hemostatic factors, lipid factors anti endothelial function in women under-going surgical menopause: implications for prevention of atherosclerosis. Am. Heart J. 134: 764-771 (1997)

37.  Mendelsohn M.E., Karas R.H.: Estrogen and the blood vessel wall. Curr. Opin. Cardiol. 9: 619-626 (1994)

38.  Losordo D.W., Kearney M.p Kim E.A., Jekanowski J., Isner J.: Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89: 1501-1510 (1994)

39.  Caulin-Glaser T., Watson C.A., Pardi R., Bender J.R.: Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J. Clin. Invest. 98: 36- 42 (1996)

40.  Gaulin-Glaser T., Farrell W.J., Pfau S.E., Zaret B.p Bunger K., Setaro J.F., Brennan J.J., Bender J.R., Cleman M.W., Cabin H.S., Remetz M.S.: Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J. Am. Coll. Cardiol. 31: 1555-1560 (1998)

41.  Ahmed S.A., Penhale W.J., Tatal N.: Sex hormones, immune responses and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 121: 531-551 (1985)

42.  Lahita R.G.: Sex hormones as immunomodulators of disease. Ann. N.Y. Acad. Sci. 685: 278-287 (1993)

43.  Jungers P., Kuttenn F., Liote E., Pelissiler 6., Athea N., Laurent M.C., Viriot J., Dougados M.P Bach J.F.: Hormonal modulation in systemic lupus erythematosus. Arthritis Rheum. 28: 1243-1250 (1985)

44.  Cutolo M., Sulli A., Seriolo B., Accardo S., Mast A.T.: Estrogens, the immune response and autoimmunity. Clin. Exper. Rheumatol. 13: 217-226 (1995)

45.  Tang M.X., Jacobs D., Stern Y., Marder K.p Schofield P., Gurland B., Andrews A., Mayeux R.: Effect of oestrogen during menopause on risk and age of onset of Alzheimer’s disease. Lancet 348: 429-432 (1996)

46.  Garcia-Segura L.M., Chowen JA, Duenas M., Torres-Aleman l., Naftolin F.: Gonadal steroids as promoters of neuro-glial plasticity. Psychoneuroendocrinology 19: 445- 453(1994)

47.  Garcia-Segura L.M., Chowen J.A., Duenas M., Parducz A., Naftolin F.: Gonadal steroids and astroglial plasticity. Cell. Mol. Neurobiol. 16: 225-237 (1996)

48.  Ohkura T., Isse K., Akazawa K.: Low-dose estrogen replacement therapy for Alzheimer’s disease in women. Menopause 1: 125-130 (1994)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr